Man's brain turned to glass by hot Vesuvius ash cloud
Nearly 2,000 years after a young man died in the Vesuvius volcanic eruption, scientists have discovered that his brain was preserved when it turned to glass in an extremely hot cloud of ash.
Researchers found the glass in 2020 and speculated that it was a fossilised brain but did not know how it had formed.
The pea-sized chunks of black glass were found inside the skull of the victim, aged about 20, who died when the volcano erupted in 79 AD near modern-day Naples.
Scientists now believe a cloud of ash as hot as 510C enveloped the brain then very quickly cooled down, transforming the organ into glass.
It is the only known case of human tissue - or any organic material - turning to glass naturally.
"We believe that the very specific conditions that we have reconstructed for the vitrification [the process of something turning into glass] of the brain make it very difficult for there to be other similar remains, although it is not impossible," Prof Guido Giordano from Università Roma Tre told BBC News.
"This is a unique finding," he said.
The brain belonged to a man killed in his bed inside a building called the Collegium on the main street of the Roman city Herculaneum.
The fragments of glass found by the scientists range from 1-2 cm to just few millimetres in size.
The massive eruption of Vesuvius engulfed Herculaneum and nearby Pompeii where up to 20,000 people lived. The remains of about 1,500 people have been found.
Scientists now think the hot ash cloud descended from Vesuvius first, probably causing most of the deaths.
A fast-moving current of hot gas and volcanic matter, also called a pyroclastic flow, followed, burying the area.
Experts believe the ash cloud turned the man's brain into glass because the pyroclastic flow would not have reached high enough temperatures or cooled quickly enough.
The process of glass formation requires very specific temperature conditions and rarely occurs naturally.
For a substance to turn to glass, there must be a huge temperature difference between the substance and its surrounding.
Its liquid form has to cool fast enough not to crystallise when it becomes solid, and it must be at a much higher temperature than its surroundings.
The team used imaging with x-rays and electron microscopy to conclude that the brain must have been heated to at least 510C before cooling rapidly.
No other parts of the man's body are believed to have turned to glass.
Only material containing some liquid can turn to glass, meaning that the bones could not have vitrified.
Other soft tissues, like organs, were likely destroyed by the heat before they could cool down enough to turn to glass.
The scientists believe the skull gave some protection to the brain.
The research is published in the scientific journal - a publication where researchers report their work to other experts - Scientific Reports.
'Once-in-a-century' discovery reveals spectacular luxury of Pompeii
First glimpse inside burnt scroll after 2,000 years

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Ancient Romans snacked on deep-fried songbirds
Fast food didn't start with McDonald's—quick, convenient meals have been a dietary staple of busy societies for millennia. Across the Roman empire, roadside shops known as popinae and tabernae often served up inexpensive, affordable dishes to hungry locals and travelers alike. But after scouring ancient garbage piles near one such popina in Mallorca, Spain, archeologists are better understanding how certain entrées transcended class divisions more often than previously thought. According to findings recently published in the International Journal of Osteoarchaeology, Roman commoners frequently enjoyed dining on thrushes—small songbirds once thought to be a luxury dish. Birds were prominent figures in ancient Rome. Certain owls and eagles were considered powerful divinatory omens, while smaller avian species like thrushes were popular as both pets and meals. In the latter case, however, ancient texts suggest thrushes were primarily eaten by wealthier Romans. 'Classical sources frequently describe these small birds as a delicacy served in elite banquets, often prepared with elaborate culinary techniques,' the study's authors write. They also cite recipes documented by Pliny the Elder and Apicius that described fattening songbirds with figs before roasting and serving them with complex sauces. These assumptions were recently challenged by finds at an excavation in Mallorca, Spain. There, archeologists from the Mediterranean Institute for Advanced Studies (IMEDEA) uncovered a large cesspit beside a roadside popina snack bar. The building also featured six amphorae (large vats) embedded in its countertop in a configuration like the one seen in Pompeii's famous street food court, or thermopolia. Amid the refuse were 165 thrush bones alongside other common food remains like sea shells as well as fish and pig bones. The condition of the songbirds' broken bones suggest that they were flattened and cooked whole with oil in the amphorae. In addition to the thrushes, archeologists also documented remains from domesticated chickens and European rabbits. These point to a wider menu tailored to everyday customers. Taken altogether, it appears that thrushes were served up similar to today's sports bar chicken wings. The food shop in Mallorca isn't the only example of deep-fried songbirds across Rome. As Arkeonews notes, additional finds in Pompeii and Britain indicates a widespread culture of ancient Roman fast food. 'Thrushes, though a minor component of the Roman diet compared to livestock, represent an important facet of urban food consumption,' the study's authors conclude. 'Ultimately, this research highlights the need to move beyond elite-centric narratives and consider the diverse ways in which food practices shaped the lived experiences of ancient urban communities.'
Yahoo
7 hours ago
- Yahoo
Scientists stunned as cameras capture footage of 200-million-year-old creature once thought extinct: 'The whole team was euphoric'
A surprising discovery has left the scientific community speechless. According to Inkl, a species previously believed to be extinct has been spotted. The unique 200-million-year-old species, famously named after Sir David Attenborough, was caught on camera in Indonesia. A group of researchers from Oxford University made the rediscovery, proving the existence of the Zaglossus Attenboroughi species, also known as Attenborough's long-beaked echidna. In the video clip, viewers can see the mammal's distinct beak and furry exterior. Before this footage, the only proof of the ancient species' existence was a specimen of a deceased Zaglossus Attenboroughi that had been preserved for museum display. However, that creature was alive "several decades ago," according to Inkl. Since echidnas roamed the planet alongside the dinosaurs, they're known as "living fossils," dating back 200 million years. The discovery of Attenborough's echidna came at the end of the researchers' expedition, concluding the trip on an exciting note. "I was euphoric, the whole team was euphoric," Dr. James Kempton, a biologist from Oxford University, told BBC News. "I'm not joking when I say it came down to the very last SD card that we looked at, from the very last camera that we collected, on the very last day of our expedition." Echidnas consist of four species, differentiated by their beaks. However, what makes these mammals so interesting is that they are one of the only mammals that lay eggs. The footage of Attenborough's echidna wasn't the only monumental discovery of the expedition. Dr. Kempton and his team also identified new insect and frog species. Discoveries like this underscore the importance of preserving the world's biodiversity. From both a scientific and cultural perspective, the discovery of Attenborough's echidna is significant. According to Inkl, in Papua local tradition, the echidna is one of the creatures that "symbolize the resolution of conflict and a return to harmonious relationships once found." Do you think we still have a lot to learn from ancient cultures? Definitely Only on certain topics I'm not sure No — not really Click your choice to see results and speak your mind. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
Yahoo
8 hours ago
- Yahoo
Regeneron and Sanofi's dupilumab shows promise in AD trial
Regeneron Pharmaceuticals and Sanofi have announced promising outcomes from the open-label Phase IV DISCOVER trial of Dupixent(dupilumab) in treating moderate-to-severe atopic dermatitis (AD) in adolescents and adults with skin of colour. The data were presented at the 2025 Revolutionizing Atopic Dermatitis Conference. In the study, 120 subjects with AD and skin of colour received Dupixent biweekly. At the 24-week mark, 76% of them achieved a ≥75% improvement in overall disease severity, with some noticing benefits as early as two weeks. Additionally, 53% of patients saw a reduction in itch, and there was a 53% decrease in post-inflammatory hyperpigmentation from baseline. The trial's safety outcomes aligned with Dupixent's established safety profile in dermatological uses. Subjects in the DISCOVER trial, aged 12 years and above, were treated with Dupixent monotherapy based on weight. The primary endpoint was achieving a minimum of a 75% improvement on the Eczema Area and Severity Index (EASI-75) at 24 weeks. Secondary and additional endpoints are the proportion of subjects achieving ≥4-point improvement on the Peak-Pruritus Numerical Rating Scale (PP-NRS). The skin of colour was defined as per Fitzpatrick skin types IV-VI. AD, a chronic skin condition characterised by type 2 inflammation, can be particularly severe in individuals with skin of colour, often leading to more pronounced symptoms and skin lesions. Invented using Regeneron's VelocImmune technology, Dupixent is a monoclonal antibody that blocks the signalling of interleukin-4 and interleukin-13 pathways without being an immunosuppressant. It is a collaborative effort between Sanofi and Regeneron. The companies recently reported that the Phase III AERIFY-1 trial of itepekimab in former smokers who have inadequately controlled chronic obstructive pulmonary disease (COPD), met the primary goal. "Regeneron and Sanofi's dupilumab shows promise in AD trial" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio